"Rolling out new anti-tuberculosis drugs without diagnostic capacity". T. Ness, L.H. Van, I. Petermane, R. Duarte, C. Lange, D. Menzies and D.M. Cirillo on behalf of the UNITE4TB Consortium. Breathe 2023; 19: 230084

This article from the June 2023 issue of Breathe was published without complete funding information. The support statement is as follows.

Support statement: This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement number 101007873. The JU receives support from the European Union's Horizon 2020 research and innovation programme and EFPIA, Deutsches Zentrum für Infektionsforschung e.V. (DZIF), and Ludwig-Maximilians Universität Munich (LMU). EFPIA/AP contribute to 50% of funding, whereas the contribution of DZIF and the LMU University Hospital Munich has been granted by the German Federal Ministry of Education and Research.

The article has been corrected and republished online.

留言 (0)

沒有登入
gif